Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules.
- 2025-07-31
- RCT
- Scientific reports 15(1)
- Asada Leelahavanichkul
- Pornpimol Phuengmaung
- Thansita Bhunyakarnjanarat
- Warerat Kaewduangduen
- Pimmada Boonnaj
- Pichanan Tengamnuay
- Wiwat Chancharoenthana
- Somkanya Tungsanga
- Suwasin Udomkarnjananun
- Somying Tumwasorn
- PubMed: 40744977
- DOI: 10.1038/s41598-025-12768-z
- High evidence
- Rigorous Journal
4-week-L34 administration reduced gut-derived uremic toxins (GDUTs), except total IS
- Effect
- Beneficial
- Effect size
- Moderate